<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Insmed Inc. | Company News & Executive Profiles - INSM | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/insmed+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Insmed Inc.]]></description>
	<s:counts start="0" returned="10" found="18" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Value Investors Know Insmed's Cash Wealth Offers No Margin of Safety]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F174991-value-investors-know-insmed-s-cash-wealth-offers-no-margin-of-safety%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Saj Karsan submits: As value investors, we often foray into areas of investment that nobody else will. Current earnings may be poor, the outlook uncertain, and the returns not expected for several years. In return for these sacrifices, we require one attribute on which we are unwilling to compromise: A...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 24 Nov 2009 02:29:05 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/saj+karsan.html"><![CDATA[Saj Karsan]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">INSM,MRK</category>
	</item>
	<item>
		<title><![CDATA[Insmed Still Looks Very Undervalued]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172200-insmed-still-looks-very-undervalued%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Jae Jun submits:  Insmed INSM continues to be a Benjamin Graham Net Net stock. As I mentioned in my October portfolio update, I was waiting for the quarterly results to be released before I took further action.   INSM Still a Net Net Stock  After a full...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 09 Nov 2009 06:16:18 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jae+jun.html"><![CDATA[Jae Jun]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="tickers">INSM</category>
	</item>
	<item>
		<title><![CDATA[Insmed Is Well Positioned to Make a Good Deal]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F163714-insmed-is-well-positioned-to-make-a-good-deal%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Jae Jun submits:  When you look hard enough and turn over enough stones, you are bound to find something sooner or later. One company I found and purchased recently is Insmed, Inc. INSM.   Before going into what it does, the company is a pure Benjamin Graham net...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 28 Sep 2009 11:42:50 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jae+jun.html"><![CDATA[Jae Jun]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="tickers">INSM</category>
	</item>
	<item>
		<title><![CDATA[Insmed's Monday Morning Press Release: Reading Between the Lines]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F151698-insmed-s-monday-morning-press-release-reading-between-the-lines%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Insmed INSM issued an early morning press release on Monday stating that the company, for the most part, will cease all operations regarding the advancement of IPLEX. The PR was accompanied by a trading halt that was in effect for about half an hour.According to the report,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 28 Jul 2009 12:14:25 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="tickers">INSM</category>
	</item>
	<item>
		<title><![CDATA[Insmed's Good End of the Deal]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F149757-insmed-s-good-end-of-the-deal%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  When Insmed Inc. INSM sold its Follow-On-Biologics [FOB] pipeline to Merck & Co. MRK for $130 million back in March, it may have been a better deal for the company than thought at the time.With four FOB candidates moving steadily along in the pipeline, Insmed prepared to...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 20 Jul 2009 01:10:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">INSM,MRK</category>
	</item>
	<item>
		<title><![CDATA[How Majesco Helped Me Win with Insmed: Lessons in Speculative Investing]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F147927-how-majesco-helped-me-win-with-insmed-lessons-in-speculative-investing%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Wall Street Cheat Sheet submits:  Jim Cramer says a lot of contradictory things when it comes to predictions, but he doesn&#8217;t waver from at least one piece of critical advice: risk only what you can afford to lose on spec plays. Thursday a biotech spec play called Insmed Inc....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 09 Jul 2009 08:23:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/wall+street+cheat+sheet.html"><![CDATA[wall street cheat sheet]]></category>
		<category domain="http://resources.bnet.com/topic/majesco+entertainment+co..html"><![CDATA[Majesco Entertainment Co.]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">COOL</category>
		<category domain="tickers">INSM,COOL</category>
	</item>
	<item>
		<title><![CDATA[Attention Outraged Insmed Investors: Today Is a New Trading Day]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F145555-attention-outraged-insmed-investors-today-is-a-new-trading-day%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  As has already been posted here, shares of Insmed INSM were cut in half on Thursday after the release of sub-par results in an exploratory Phase II trial.The amount of negative investor response to the MMD press release and subsequent collapse of the stock intrigues me. Certainly,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 26 Jun 2009 04:27:47 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="tickers">INSM</category>
	</item>
	<item>
		<title><![CDATA[Insmed Stock Rising on High Volume, But Still a Good Buy]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F141947-insmed-stock-rising-on-high-volume-but-still-a-good-buy%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Based on the volatility of the stock that has been accompanied by days of high trading volume, I've been predicting for weeks now that Insmed INSM was gearing up to release some significant news, most likely regarding the preliminary data collected from a Phase II trial measuring...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 08 Jun 2009 04:09:53 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="tickers">INSM</category>
	</item>
	<item>
		<title><![CDATA[Will Insmed's IPLEX Meet Expectations?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F138180-will-insmed-s-iplex-meet-expectations%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Insmed Inc INSM released its first quarter results last week, which included a $130 million payment from Merck MRK that completed the sale of Insmed's Follow-on-Biologics (FOB) platform which was agreed to in February. Since news of the sale was announced, INSM has inched higher from the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 18 May 2009 02:19:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="tickers">INSM</category>
	</item>
	<item>
		<title><![CDATA[Insmed Incorporated Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224344.html]]></link>
		<description><![CDATA[ Earnings Call ExcerptInsmed Incorporated INSM Q2 2008 Earnings Call Transcript August 8, 2008 8:30 am ET Executives  Brian Ritchie &#8211; FD Geoff Allan &#8211; President and CEO Kevin Tully &#8211; EVP and CFO Presentation  Operator Good day, ladies and gentlemen, and welcome to the second quarter 2008...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 08 Aug 2008 07:46:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="tickers">INSM</category>
	</item>
</channel>
</rss>
